Decoding the knots of initiation of oncogenic epithelial-mesenchymal transition in tumor progression

Current Cancer Drug Targets

Volumn 13, Issue 9, 2013, Pages 996-1011

  Guo, Pengda ^a   Gao, Aidi ^a   Zhang, Gaochuan ^a   Han, Hongyan ^a   Zhou, Quansheng ^a  

^a THE FIRST AFFILIATED HOSPITAL OF SOOCHOW UNIVERSITY   (China)

Author keywords

Cancer stem cells; EMT; Microenvironment; MiRNA; Oncogene; Tumor metastasis; Tumor suppressor

Indexed keywords

BMI1 PROTEIN; CARCINOGEN; CONNECTIVE TISSUE GROWTH FACTOR; MICRORNA; OCTAMER TRANSCRIPTION FACTOR 4; PHOSPHATIDYLINOSITOL 3, 4, 5 TRISPHOSPHATE 3 PHOSPHATASE; PROTEIN P21; PROTEIN P53; RAS PROTEIN; TRANSCRIPTION FACTOR GLI1; TRANSCRIPTION FACTOR NANOG; TRANSCRIPTION FACTOR SLUG; TRANSCRIPTION FACTOR TWIST; TRANSCRIPTION FACTOR ZEB1; UNCLASSIFIED DRUG;

ARTICLE; CANCER STEM CELL; CARCINOGENESIS; EPITHELIAL MESENCHYMAL TRANSITION; EPSTEIN BARR VIRUS; HEPATITIS VIRUS; HUMAN; HYPOXIA; METASTASIS; NONHUMAN; ONCOGENE; OXIDATIVE STRESS; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; TUMOR MICROENVIRONMENT; TUMOR SUPPRESSOR GENE;

CARCINOGENESIS; DISEASE PROGRESSION; EPITHELIAL-MESENCHYMAL TRANSITION; HUMANS; ONCOGENES; SIGNAL TRANSDUCTION; TUMOR MICROENVIRONMENT;

EID: 84890845231     PISSN: 15680096     EISSN: 18735576     Source Type: Journal    
DOI: 10.2174/15680096113136660105     Document Type: Article

References (213)

1. Greenburg, G.; Hay, E. D. Epithelia suspended in collagen gels can lose polarity and express characteristics of migrating mesenchymal cells. J. Cell Biol. 1982, 95(1), 333-339.
2. Kalluri, R.; Weinberg, R. A. The basics of epithelial-mesenchymal transition. J. Clin. Invest. 2009, 119(6), 1420-1428.
3. Thiery, J. P.; Acloque, H.; Huang, R. Y.; Nieto, M. A. Epithelialmesenchymal transitions in development and disease. Cell 2009, 139(5), 871-890.
4. Rhim, A. D. Epithelial to mesenchymal transition and the generation of stem-like cells in pancreatic cancer. Pancreatology 2013, 13(2), 114-117.
5. Lan, L.; Luo, Y.; Cui, D.; Shi, B. Y.; Deng, W.; Huo, L. L.; Chen, H. L.; Zhang, G. Y.; Deng, L. L. Epithelial-mesenchymal transition triggers cancer stem cell generation in human thyroid cancer cells. Int. J. Oncol. 2013, 43(1), 113-120.
6. van de Stolpe, A. On the origin and destination of cancer stem cells: a conceptual evaluation. Am. J. Cancer Res. 2013, 3(1), 107-116.
7. Rhim, A. D.; Mirek, E. T.; Aiello, N. M.; Maitra, A.; Bailey, J. M.; McAllister, F.; Reichert, M.; Beatty, G. L.; Rustgi, A. K.; Vonderheide, R. H.; Leach, S. D.; Stanger, B. Z. EMT and dissemination precede pancreatic tumor formation. Cell 2012, 148(1-2), 349-361.
8. Thiery, J. P. Epithelial mesenchymal transitions in tumour progression. Nat. Rev. Cancer 2002, 2(6), 442-454.
9. Tsuji, T.; Ibaragi, S.; Hu, G.-f. Epithelial-mesenchymal transition and cell cooperativity in metastasis. Cancer Res. 2009, 69(18), 7135-7139.
10. Yang, J.; Weinberg, R. A. Epithelial-mesenchymal transition: at the crossroads of development and tumor metastasis. Dev. Cell 2008, 14(6), 818-829.
11. Oliveras-Ferraros, C.; Corominas-Faja, B.; Cufi, S.; Vazquez-Martin, A.; Martin-Castillo, B.; Iglesias, J. M.; Lopez-Bonet, E.; Martin, A. G.; Menendez, J. A. Epithelial-to-mesenchymal transition (EMT) confers primary resistance to trastuzumab (Herceptin). Cell Cycle 2012, 11(21), 4020-4032.
12. Foroni, C.; Broggini, M.; Generali, D.; Damia, G. Epithelialmesenchymal transition and breast cancer: role, molecular mechanisms and clinical impact. Cancer Treat. Rev. 2012, 38(6), 689-697.
13. Gunasinghe, N. P.; Wells, A.; Thompson, E. W.; Hugo, H. J. Mesenchymal-epithelial transition (MET) as a mechanism for metastatic colonisation in breast cancer. Cancer Metass. Rev. 2012, 31(3-4), 469-478.
14. Nurwidya, F.; Takahashi, F.; Murakami, A.; Takahashi, K. Epithelial mesenchymal transition in drug resistance and metastasis of lung cancer. Cancer Res. Treat. 2012, 44(3), 151-156.
15. Nauseef, J. T.; Henry, M. D. Epithelial-to-mesenchymal transition in prostate cancer: paradigm or puzzle? Nat. Rev. Urol. 2011, 8(8), 428-439.
16. Karamitopoulou, E. Tumor budding cells, cancer stem cells and epithelial-mesenchymal transition-type cells in pancreatic cancer. Front. Oncol. 2012, 2, 209.
17. Davidson, B.; Trope, C. G.; Reich, R. Epithelial-mesenchymal transition in ovarian carcinoma. Front. Oncol. 2012, 2, 33.
18. Huang, R. Y.; Chung, V. Y.; Thiery, J. P. Targeting pathways contributing to epithelial-mesenchymal transition (EMT) in epithelial ovarian cancer. Curr. Drug Targets 2012, 13(13), 1649-1653.
19. Zlobec, I.; Lugli, A. Epithelial mesenchymal transition and tumor budding in aggressive colorectal cancer: tumor budding as oncotarget. Oncotarget 2010, 1(7), 651-661.
20. Bhangu, A.; Wood, G.; Mirnezami, A.; Darzi, A.; Tekkis, P.; Goldin, R. Epithelial mesenchymal transition in colorectal cancer: Seminal role in promoting disease progression and resistance to neoadjuvant therapy. Surg. Oncol. 2012, 21(4), 316-323.
21. Natalwala, A.; Spychal, R.; Tselepis, C. Epithelial-mesenchymal transition mediated tumourigenesis in the gastrointestinal tract. World J. Gastroenterol. 2008, 14(24), 3792-3797.
22. Matsuoka, J.; Yashiro, M.; Doi, Y.; Fuyuhiro, Y.; Kato, Y.; Shinto, O.; Noda, S.; Kashiwagi, S.; Aomatsu, N.; Hirakawa, T.; Hasegawa, T.; Shimizu, K.; Shimizu, T.; Miwa, A.; Yamada, N.; Sawada, T.; Hirakawa, K. Hypoxia stimulates the EMT of gastric cancer cells through autocrine TGFbeta signaling. PLoS One 2013, 8(5), e62310.
23. Ogunwobi, O. O.; Liu, C. Therapeutic and prognostic importance of epithelial-mesenchymal transition in liver cancers: insights from experimental models. Crit. Rev. Oncol. Hematol. 2012, 83(3), 319-328.
24. van Zijl, F.; Zulehner, G.; Petz, M.; Schneller, D.; Kornauth, C.; Hau, M.; Machat, G.; Grubinger, M.; Huber, H.; Mikulits, W. Epithelial-mesenchymal transition in hepatocellular carcinoma. Future Oncol. 2009, 5(8), 1169-1179.
25. Shan, Y.; Zhang, L.; Bao, Y.; Li, B.; He, C.; Gao, M.; Feng, X.; Xu, W.; Zhang, X.; Wang, S. Epithelial-mesenchymal transition, a novel target of sulforaphane via COX-2/MMP2, 9/Snail, ZEB1 and miR-200c/ZEB1 pathways in human bladder cancer cells. J. Nutr. Biochem. 2013, 24(6), 1062-1069.
26. Tomizawa, Y.; Wu, T. T.; Wang, K. K. Epithelial mesenchymal transition and cancer stem cells in esophageal adenocarcinoma originating from Barrett's esophagus. Oncol. Lett. 2012, 3(5), 1059-1063.
27. Harada, K.; Miyake, H.; Kusuda, Y.; Fujisawa, M. Expression of epithelial-mesenchymal transition markers in renal cell carcinoma: impact on prognostic outcomes in patients undergoing radical nephrectomy. BJU Int. 2012, 110(11 Pt C), E1131-E1137.
28. Kahlert, U. D.; Nikkhah, G.; Maciaczyk, J. Epithelial-tomesenchymal(-like) transition as a relevant molecular event in malignant gliomas. Cancer Lett. 2013, 331(2), 131-138.
29. Nagaishi, M.; Paulus, W.; Brokinkel, B.; Vital, A.; Tanaka, Y.; Nakazato, Y.; Giangaspero, F.; Ohgaki, H. Transcriptional factors for epithelial-mesenchymal transition are associated with mesenchymal differentiation in gliosarcoma. Brain Pathol. 2012, 22(5), 670-676.
30. Nakamura, M.; Tokura, Y. Epithelial-mesenchymal transition in the skin. J. Dermatol. Sci. 2011, 61(1), 7-13.
31. Downward, J. Targeting RAS signalling pathways in cancer therapy. Nat. Rev. Cancer 2003, 3(1), 11-22.
32. Stites, E. C.; Ravichandran, K. S. A systems perspective of Ras signaling in cancer. Clin. Cancer Res. 2009, 15(5), 1510-1513.
33. Doehn, U.; Hauge, C.; Frank, S. R.; Jensen, C. J.; Duda, K.; Nielsen, J. V.; Cohen, M. S.; Johansen, J. V.; Winther, B. R.; Lund, L. R.; Winther, O.; Taunton, J.; Hansen, S. H.; Frodin, M. RSK is a principal effector of the RAS-ERK pathway for eliciting a coordinate promotile/invasive gene program and phenotype in epithelial cells. Mol. Cell 2009, 35(4), 511-522.
34. Pelaez, I. M.; Kalogeropoulou, M.; Ferraro, A.; Voulgari, A.; Pankotai, T.; Boros, I.; Pintzas, A. Oncogenic RAS alters the global and gene-specific histone modification pattern during epithelialmesenchymal transition in colorectal carcinoma cells. Int. J. Biochem. Cell Biol. 2010, 42(6), 911-920.
35. Zhang, J.; Lei, Y.; Gao, X.; Liang, Q.; Li, L.; Feng, J.; Hou, P.; Han, L.; Zhang, Y.; Huang, B. p53 Attenuates the oncogenic Rasinduced epithelial-mesenchymal transition in human mammary epithelial cells. Biochem. Bioph. Res. Co. 2013, 434(3), 606-613
36. Tauro, B. J.; Mathias, R. A.; Greening, D. W.; Gopal, S. K.; Ji, H.; Kapp, E. A.; Coleman, B. M.; Hill, A. F.; Kusebauch, U.; Hallows, J. L.; Shteynberg, D.; Moritz, R. L.; Zhu, H. J.; Simpson, R. J. Oncogenic H-Ras reprograms Madin-Darby canine kidney (MDCK) cell-derived exosomal proteins following epithelialmesenchymal transition. Mol. Cell. Proteomics 2013, 12(8), 2148-2159.
37. Allegra, M.; Zaragkoulias, A.; Vorgia, E.; Ioannou, M.; Litos, G.; Beug, H.; Mavrothalassitis, G. Semaphorin-7a reverses the ERF induced inhibition of EMT in Ras-dependent mouse mammary epithelial cells. Mol. Biol. Cell 2012, 23(19), 3873-3881.
38. Vuoriluoto, K.; Haugen, H.; Kiviluoto, S.; Mpindi, J. P.; Nevo, J.; Gjerdrum, C.; Tiron, C.; Lorens, J. B.; Ivaska, J. Vimentin regulates EMT induction by Slug and oncogenic H-Ras and migration by governing Axl expression in breast cancer. Oncogene 2011, 30(12), 1436-1448.
39. Wang, Z.; Ali, S.; Banerjee, S.; Bao, B.; Li, Y.; Azmi, A. S.; Korc, M.; Sarkar, F. H. Activated K-Ras and INK4a/Arf deficiency promote aggressiveness of pancreatic cancer by induction of EMT consistent with cancer stem cell phenotype. J. Cell. Physiol. 2013, 228(3), 556-562.
40. Lahsnig, C.; Mikula, M.; Petz, M.; Zulehner, G.; Schneller, D.; van Zijl, F.; Huber, H.; Csiszar, A.; Beug, H.; Mikulits, W. ILEI requires oncogenic Ras for the epithelial to mesenchymal transition of hepatocytes and liver carcinoma progression. Oncogene 2009, 28(5), 638-650.
41. Joyce, T.; Oikonomou, E.; Kosmidou, V.; Makrodouli, E.; Bantounas, I.; Avlonitis, S.; Zografos, G.; Pintzas, A. A Molecular signature for oncogenic BRAF in human colon cancer cells is revealed by microarray analysis. Curr. Cancer Drug Targets 2012, 12(7), 873-898.
42. Lan, M.; Kojima, T.; Osanai, M.; Chiba, H.; Sawada, N. Oncogenic Raf-1 regulates epithelial to mesenchymal transition via distinct signal transduction pathways in an immortalized mouse hepatic cell line. Carcinogenesis 2004, 25(12), 2385-2395.
43. Leontovich, A. A.; Zhang, S.; Quatraro, C.; Iankov, I.; Veroux, P. F.; Gambino, M. W.; Degnim, A.; McCubrey, J.; Ingle, J.; Galanis, E.; D'Assoro, A. B. Raf-1 oncogenic signaling is linked to activation of mesenchymal to epithelial transition pathway in metastatic breast cancer cells. Int. J. Oncol. 2012, 40(6), 1858-1864.
44. Makrodouli, E.; Oikonomou, E.; Koc, M.; Andera, L.; Sasazuki, T.; Shirasawa, S.; Pintzas, A. BRAF and RAS oncogenes regulate Rho GTPase pathways to mediate migration and invasion properties in human colon cancer cells: a comparative study. Mol. Cancer 2011, 10, 118.
45. Lin, K.; Baritaki, S.; Militello, L.; Malaponte, G.; Bevelacqua, Y.; Bonavida, B. The Role of B-RAF Mutations in Melanoma and the Induction of EMT via Dysregulation of the NFkappaB/ Snail/RKIP/PTEN Circuit. Genes Cancer 2010, 1(5), 409-420.
46. Zhang, J.-X.; Huang, X.-X.; Cai, M.-B.; Tong, Z.-T.; Chen, J.-W.; Qian, D.; Liao, Y.-J.; Deng, H.-X.; Liao, D.-Z.; Huang, M.-Y. Overexpression of the secretory small GTPase Rab27B in human breast cancer correlates closely with lymph node metastasis and predicts poor prognosis. J. Transl. Med. 2012, 10(1), 1-10.
47. Liu, M.; Zhu, H.; Yang, S.; Wang, Z.; Bai, J.; Xu, N. c-Myc suppressed E-cadherin through miR-9 at the post-transcriptional level. Cell Biol. Int. 2013, 37(3), 197-202.
48. Cohen, D. E.; Prochownik, E. V. A functional hierarchy for c-Myc target genes? Lessons from MT-MC1. Cell Cycle 2006, 5(4), 392-393.
49. Riggs, J. W.; Barrilleaux, B. L.; Varlakhanova, N.; Bush, K. M.; Chan, V.; Knoepfler, P. S. Induced pluripotency and oncogenic transformation are related processes. Stem Cells Dev. 2013, 22(1), 37-50.
50. Zhang, G.; Shang, B.; Yang, P.; Cao, Z.; Pan, Y.; Zhou, Q. Induced pluripotent stem cell consensus genes: implication for the risk of tumorigenesis and cancers in induced pluripotent stem cell therapy. Stem Cells Dev. 2012, 21(6), 955-964.
51. Ischenko, I.; Zhi, J.; Moll, U. M.; Nemajerova, A.; Petrenko, O. Direct reprogramming by oncogenic Ras and Myc. Proc. Natl. Acad. Sci. USA 2013, 110(10), 3937-3942.
52. Liu, M.; Casimiro, M. C.; Wang, C.; Shirley, L. A.; Jiao, X.; Katiyar, S.; Ju, X.; Li, Z.; Yu, Z.; Zhou, J.; Johnson, M.; Fortina, P.; Hyslop, T.; Windle, J. J.; Pestell, R. G. p21CIP1 attenuates Rasand c-Myc-dependent breast tumor epithelial mesenchymal transition and cancer stem cell-like gene expression in vivo. Proc. Natl. Acad. Sci. USA 2009, 106(45), 19035-19039.
53. Bai, J. X.; Yan, B.; Zhao, Z. N.; Xiao, X.; Qin, W. W.; Zhang, R.; Jia, L. T.; Meng, Y. L.; Jin, B. Q.; Fan, D. M.; Wang, T.; Yang, A. G. Tamoxifen represses miR-200 microRNAs and promotes epithelial-to-mesenchymal transition by up-regulating c-Myc in endometrial carcinoma cell lines. Endocrinology 2013, 154(2), 635-645.
54. Amatangelo, M. D.; Goodyear, S.; Varma, D.; Stearns, M. E. c-Myc expression and MEK1-induced Erk2 nuclear localization are required for TGF-beta induced epithelial-mesenchymal transition and invasion in prostate cancer. Carcinogenesis 2012, 33(10), 1965-1975.
55. Sakuma, K.; Aoki, M.; Kannagi, R. Transcription factors c-Myc and CDX2 mediate E-selectin ligand expression in colon cancer cells undergoing EGF/bFGF-induced epithelial-mesenchymal transition. Proc. Natl. Acad. Sci. USA 2012, 109(20), 7776-7781.
56. Leung, J. Y.; Andrechek, E. R.; Cardiff, R. D.; Nevins, J. R. Heterogeneity in MYC-induced mammary tumors contributes to escape from oncogene dependence. Oncogene 2012, 31(20), 2545-2554.
57. Trimboli, A. J.; Fukino, K.; de Bruin, A.; Wei, G.; Shen, L.; Tanner, S. M.; Creasap, N.; Rosol, T. J.; Robinson, M. L.; Eng, C. Direct evidence for epithelial-mesenchymal transitions in breast cancer. Cancer Res. 2008, 68(3), 937-945.
58. Leung, C.; Lingbeek, M.; Shakhova, O.; Liu, J.; Tanger, E.; Saremaslani, P.; van Lohuizen, M.; Marino, S. Bmi1 is essential for cerebellar development and is overexpressed in human medulloblastomas. Nature 2004, 428(6980), 337-341.
59. Siddique, H. R.; Saleem, M. Role of BMI1, a stem cell factor, in cancer recurrence and chemoresistance: preclinical and clinical evidences. Stem Cells 2012, 30(3), 372-378.
60. Yang, M.-H.; Hsu, D. S.-S.; Wang, H.-W.; Wang, H.-J.; Lan, H.-Y.; Yang, W.-H.; Huang, C.-H.; Kao, S.-Y.; Tzeng, C.-H.; Tai, S.-K. Bmi1 is essential in Twist1-induced epithelial-mesenchymal transition. Nat. Cell Biol. 2010, 12(10), 982-992.
61. Chou, C. H.; Yang, N. K.; Liu, T. Y.; Tai, S. K.; Hsu, D. S.; Chen, Y. W.; Chen, Y. J.; Chang, C. C.; Tzeng, C. H.; Yang, M. H. Chromosome instability modulated by BMI1-AURKA signaling drives progression in head and neck cancer. Cancer Res. 2013, 73(2), 953-966.
62. Wu, K. J.; Yang, M. H. Epithelial-mesenchymal transition and cancer stemness: the Twist1-Bmi1 connection. Biosci. Rep. 2011, 31(6), 449-455.
63. Wu, C. Y.; Hung, J. J.; Wu, K. J. Linkage between Twist1 and Bmi1: molecular mechanism of cancer metastasis/stemness and clinical implications. Clin. Exp. Pharmacol. P. 2012, 39(8), 668-673.
64. Sun, L.; Yao, Y.; Liu, B.; Lin, Z.; Lin, L.; Yang, M.; Zhang, W.; Chen, W.; Pan, C.; Liu, Q.; Song, E.; Li, J. MiR-200b and miR-15b regulate chemotherapy-induced epithelial-mesenchymal transition in human tongue cancer cells by targeting BMI1. Oncogene 2012, 31(4), 432-445.
65. Bao-Hong, G.; Yan, F.; Rong, Z.; Li-Hua, X.; Man-Zhi, L.; Hsiang-Fu, K.; Li-Bing, S.; Mu-Sheng, Z. Bmi-1 promotes invasion and metastasis, and its elevated expression is correlated with an advanced stage of breast cancer. Mol. Cancer 2011, 28, 10(1), 10.
66. Katoh, Y.; Katoh, M. Integrative genomic analyses on GLI1: positive regulation of GLI1 by Hedgehog-GLI, TGFbeta-Smads, and RTK-PI3K-AKT signals, and negative regulation of GLI1 by Notch-CSL-HES/HEY, and GPCR-Gs-PKA signals. Int. J. Oncol. 2009, 35(1), 187-192.
67. Xu, X.; Zhou, Y.; Xie, C.; Wei, S. M.; Gan, H.; He, S.; Wang, F.; Xu, L.; Lu, J.; Dai, W.; He, L.; Chen, P.; Wang, X.; Guo, C. Genome-wide screening reveals an EMT molecular network mediated by Sonic hedgehog-Gli1 signaling in pancreatic cancer cells. PLoS One 2012, 7(8), e43119.
68. Zheng, X.; Yao, Y.; Xu, Q.; Tu, K.; Liu, Q. Evaluation of gliomaassociated oncogene 1 expression and its correlation with the expression of sonic hedgehog, E-cadherin and S100a4 in human hepatocellular carcinoma. Mol. Med. Rep. 2010, 3(6), 965-970.
69. Zheng, X.; Vittar, N. B.; Gai, X.; Fernandez-Barrena, M. G.; Moser, C. D.; Hu, C.; Almada, L. L.; McCleary-Wheeler, A. L.; Elsawa, S. F.; Vrabel, A. M.; Shire, A. M.; Comba, A.; Thorgeirsson, S. S.; Kim, Y.; Liu, Q.; Fernandez-Zapico, M. E.; Roberts, L. R. The transcription factor GLI1 mediates TGFbeta1 driven EMT in hepatocellular carcinoma via a SNAI1-dependent mechanism. PLoS One 2012, 7(11), e49581.
70. Joost, S.; Almada, L. L.; Rohnalter, V.; Holz, P. S.; Vrabel, A. M.; Fernandez-Barrena, M. G.; McWilliams, R. R.; Krause, M.; Fernandez-Zapico, M. E.; Lauth, M. GLI1 inhibition promotes epithelial-to-mesenchymal transition in pancreatic cancer cells. Cancer Res. 2012, 72(1), 88-99.
71. Liu, X.; Sun, H.; Qi, J.; Wang, L.; He, S.; Liu, J.; Feng, C.; Chen, C.; Li, W.; Guo, Y.; Qin, D.; Pan, G.; Chen, J.; Pei, D.; Zheng, H. Sequential introduction of reprogramming factors reveals a timesensitive requirement for individual factors and a sequential EMTMET mechanism for optimal reprogramming. Nat. Cell Biol. 2013, 15(7), 829-838.
72. Guo, D.; Xu, B. L.; Zhang, X. H.; Dong, M. M. Cancer stem-like side population cells in the human nasopharyngeal carcinoma cell line cne-2 possess epithelial mesenchymal transition properties in association with metastasis. Oncol. Rep. 2012, 28(1), 241-247.
73. Chiou, S. H.; Wang, M. L.; Chou, Y. T.; Chen, C. J.; Hong, C. F.; Hsieh, W. J.; Chang, H. T.; Chen, Y. S.; Lin, T. W.; Hsu, H. S.; Wu, C. W. Coexpression of Oct4 and Nanog enhances malignancy in lung adenocarcinoma by inducing cancer stem cell-like properties and epithelial-mesenchymal transdifferentiation. Cancer Res. 2010, 70(24), 10433-10444.
74. Velpula, K. K.; Dasari, V. R.; Tsung, A. J.; Dinh, D. H.; Rao, J. S. Cord blood stem cells revert glioma stem cell EMT by down regulating transcriptional activation of Sox2 and Twist1. Oncotarget 2011, 2(12), 1028-1042.
75. Luo, W.; Li, S.; Peng, B.; Ye, Y.; Deng, X.; Yao, K. Embryonic stem cells markers SOX2, OCT4 and Nanog expression and their correlations with epithelial-mesenchymal transition in nasopharyngeal carcinoma. PLoS One 2013, 8(2), e56324.
76. Hu, J.; Guo, H.; Li, H.; Liu, Y.; Liu, J.; Chen, L.; Zhang, J.; Zhang, N. MiR-145 regulates epithelial to mesenchymal transition of breast cancer cells by targeting Oct4. PLoS One 2012, 7(9), e45965.
77. Sun, C.; Sun, L.; Jiang, K.; Gao, D. M.; Kang, X. N.; Wang, C.; Zhang, S.; Huang, S.; Qin, X.; Li, Y.; Liu, Y. K. NANOG promotes liver cancer cell invasion by inducing epithelialmesenchymal transition through NODAL/SMAD3 signaling pathway. Int. J. Biochem. Cell B. 2013, 45(6), 1099-1108.
78. Dai, X.; Ge, J.; Wang, X.; Qian, X.; Zhang, C.; Li, X. OCT4 regulates epithelial-mesenchymal transition and its knockdown inhibits colorectal cancer cell migration and invasion. Oncol. Rep. 2013, 29(1), 155-160.
79. Meng, H. M.; Zheng, P.; Wang, X. Y.; Liu, C.; Sui, H. M.; Wu, S. J.; Zhou, J.; Ding, Y. Q.; Li, J. M. Overexpression of nanog predicts tumor progression and poor prognosis in colorectal cancer. Cancer Biol. Ther. 2010, 9(4).
80. Han, X.; Fang, X.; Lou, X.; Hua, D.; Ding, W.; Foltz, G.; Hood, L.; Yuan, Y.; Lin, B. Silencing SOX2 induced mesenchymal-epithelial transition and its expression predicts liver and lymph node metastasis of CRC patients. PLoS One 2012, 7(8), e41335.
81. Li, X.; Xu, Y.; Chen, Y.; Chen, S.; Jia, X.; Sun, T.; Liu, Y.; Li, X.; Xiang, R.; Li, N. SOX2 promotes tumor metastasis by stimulating epithelial-to-mesenchymal transition via regulation of WNT/betacatenin signal network. Cancer Lett. 2013, 336(2), 379-389.
82. Zheng, H.; Kang, Y. Multilayer control of the EMT master regulators. Oncogene 2013. doi: 10.1038/onc.2013.128. [Epub ahead of print].
83. Vincent, T.; Neve, E. P.; Johnson, J. R.; Kukalev, A.; Rojo, F.; Albanell, J.; Pietras, K.; Virtanen, I.; Philipson, L.; Leopold, P. L.; Crystal, R. G.; de Herreros, A. G.; Moustakas, A.; Pettersson, R. F.; Fuxe, J. A SNAIL1-SMAD3/4 transcriptional repressor complex promotes TGF-beta mediated epithelial-mesenchymal transition. Nat. Cell Biol. 2009, 11(8), 943-950.
84. Shih, J. Y.; Yang, P. C. The EMT regulator slug and lung carcinogenesis. Carcinogenesis 2011, 32(9), 1299-1304.
85. Pallier, K.; Cessot, A.; Cote, J. F.; Just, P. A.; Cazes, A.; Fabre, E.; Danel, C.; Riquet, M.; Devouassoux-Shisheboran, M.; Ansieau, S.; Puisieux, A.; Laurent-Puig, P.; Blons, H. TWIST1 a new determinant of epithelial to mesenchymal transition in EGFR mutated lung adenocarcinoma. PLoS One 2012, 7(1), e29954.
86. Li, C.; Ren, Y.; Jia, X.; Liang, P.; Lou, W.; He, L.; Li, M.; Sun, S.; Wang, H. Twist overexpression promoted epithelial-tomesenchymal transition of human peritoneal mesothelial cells under high glucose. Nephrol. Dial. Transpl. 2012, 27(11), 4119-4124.
87. Ohashi, S.; Natsuizaka, M.; Wong, G. S.; Michaylira, C. Z.; Grugan, K. D.; Stairs, D. B.; Kalabis, J.; Vega, M. E.; Kalman, R. A.; Nakagawa, M.; Klein-Szanto, A. J.; Herlyn, M.; Diehl, J. A.; Rustgi, A. K.; Nakagawa, H. Epidermal growth factor receptor and mutant p53 expand an esophageal cellular subpopulation capable of epithelial-to-mesenchymal transition through ZEB transcription factors. Cancer Res. 2010, 70(10), 4174-4184.
88. Gemmill, R. M.; Roche, J.; Potiron, V. A.; Nasarre, P.; Mitas, M.; Coldren, C. D.; Helfrich, B. A.; Garrett-Mayer, E.; Bunn, P. A.; Drabkin, H. A. ZEB1-responsive genes in non-small cell lung cancer. Cancer Lett. 2011, 300(1), 66-78.
89. Cai, C.; Rajaram, M.; Zhou, X.; Liu, Q.; Marchica, J.; Li, J.; Powers, R. S. Activation of multiple cancer pathways and tumor maintenance function of the 3q amplified oncogene FNDC3B. Cell Cycle 2012, 11(9), 1773-1781.
90. Shah, P. P.; Kakar, S. S. Pituitary tumor transforming gene induces epithelial to mesenchymal transition by regulation of Twist, Snail, Slug, and E-cadherin. Cancer Lett. 2011, 311(1), 66-76.
91. Shah, P. P.; Fong, M. Y.; Kakar, S. S. PTTG induces EMT through integrin alphaVbeta3-focal adhesion kinase signaling in lung cancer cells. Oncogene 2012, 31(26), 3124-3135.
92. Thuault, S.; Tan, E.-J.; Peinado, H.; Cano, A.; Heldin, C.-H.; Moustakas, A. HMGA2 and Smads co-regulate SNAIL1 expression during induction of epithelial-to-mesenchymal transition. J. Biol. Chem. 2008, 283(48), 33437-33446.
93. Zha, L.; Zhang, J.; Tang, W.; Zhang, N.; He, M.; Guo, Y.; Wang, Z. HMGA2 elicits EMT by activating the Wnt/beta-catenin pathway in gastric cancer. Dig. Dis. Sci. 2013, 58(3), 724-733.
94. Luo, Y.; Li, W.; Liao, H. HMGA2 induces epithelial-to-mesenchymal transition in human hepatocellular carcinoma cells. Oncol. Lett. 2013, 5(4), 1353-1356.
95. Watanabe, S.; Ueda, Y.; Akaboshi, S.-i.; Hino, Y.; Sekita, Y.; Nakao, M. HMGA2 maintains oncogenic RAS-induced epithelialmesenchymal transition in human pancreatic cancer cells. Am. J. Pathol. 2009, 174(3), 854-868.
96. Wu, J.; Liu, Z.; Shao, C.; Gong, Y.; Hernando, E.; Lee, P.; Narita, M.; Muller, W.; Liu, J.; Wei, J. J. HMGA2 overexpression-induced ovarian surface epithelial transformation is mediated through regulation of EMT genes. Cancer Res. 2011, 71(2), 349-359.
97. Vogelstein, B.; Lane, D.; Levine, A. J. Surfing the p53 network. Nature 2000, 408(6810), 307-310.
98. Chang, C. J.; Chao, C. H.; Xia, W.; Yang, J. Y.; Xiong, Y.; Li, C. W.; Yu, W. H.; Rehman, S. K.; Hsu, J. L.; Lee, H. H.; Liu, M.; Chen, C. T.; Yu, D.; Hung, M. C. p53 regulates epithelialmesenchymal transition and stem cell properties through modulating miRNAs. Nat. Cell Biol. 2011, 13(3), 317-323.
99. Kim, T.; Veronese, A.; Pichiorri, F.; Lee, T. J.; Jeon, Y. J.; Volinia, S.; Pineau, P.; Marchio, A.; Palatini, J.; Suh, S. S.; Alder, H.; Liu, C. G.; Dejean, A.; Croce, C. M. p53 regulates epithelialmesenchymal transition through microRNAs targeting ZEB1 and ZEB2. J. Exp. Med. 2011, 208(5), 875-883.
100. Ren, D.; Wang, M.; Guo, W.; Zhao, X.; Tu, X.; Huang, S.; Zou, X.; Peng, X. Wild-type p53 suppresses the epithelial-mesenchymal transition and stemness in PC-3 prostate cancer cells by modulating miR145. Int. J. Oncol. 2013, 42(4), 1473-1481.
101. Termen, S.; Tan, E. J.; Heldin, C. H.; Moustakas, A. p53 regulates epithelial-mesenchymal transition induced by transforming growth factor beta. J. Cell. Physiol. 2013, 228(4), 801-813.
102. Roger, L.; Jullien, L.; Gire, V.; Roux, P. Gain of oncogenic function of p53 mutants regulates E-cadherin expression uncoupled from cell invasion in colon cancer cells. J. Cell Sci. 2010, 123(Pt 8), 1295-1305.
103. Kogan-Sakin, I.; Tabach, Y.; Buganim, Y.; Molchadsky, A.; Solomon, H.; Madar, S.; Kamer, I.; Stambolsky, P.; Shelly, A.; Goldfinger, N.; Valsesia-Wittmann, S.; Puisieux, A.; Zundelevich, A.; Gal-Yam, E. N.; Avivi, C.; Barshack, I.; Brait, M.; Sidransky, D.; Domany, E.; Rotter, V. Mutant p53(R175H) upregulates Twist1 expression and promotes epithelial-mesenchymal transition in immortalized prostate cells. Cell Death Differ. 2011, 18(2), 271-281.
104. Lindberg, M. E.; Stodden, G. R.; King, M. L.; Maclean, J. A., 2nd; Mann, J. L.; Demayo, F. J.; Lydon, J. P.; Hayashi, K. Loss of Cdh1 and Pten Accelerates Cellular Invasiveness and Angiogenesis in the Mouse Uterus. Biol. Reprod. 2013, 89(1), 8.
105. Shorning, B. Y.; Griffiths, D.; Clarke, A. R. Lkb1 and Pten synergise to suppress mTOR-mediated tumorigenesis and epithelialmesenchymal transition in the mouse bladder. PLoS One 2011, 6(1), e16209.
106. Bao, L.; Yan, Y.; Xu, C.; Ji, W.; Shen, S.; Xu, G.; Zeng, Y.; Sun, B.; Qian, H.; Chen, L.; Wu, M.; Su, C.; Chen, J. MicroRNA-21 suppresses PTEN and hSulf-1 expression and promotes hepatocellular carcinoma progression through AKT/ERK pathways. Cancer Lett. 2013, 337(2), 226-236.
107. Mulholland, D. J.; Kobayashi, N.; Ruscetti, M.; Zhi, A.; Tran, L. M.; Huang, J.; Gleave, M.; Wu, H. Pten loss and RAS/MAPK activation cooperate to promote EMT and metastasis initiated from prostate cancer stem/progenitor cells. Cancer Res. 2012, 72(7), 1878-1889.
108. Song, L. B.; Li, J.; Liao, W. T.; Feng, Y.; Yu, C. P.; Hu, L. J.; Kong, Q. L.; Xu, L. H.; Zhang, X.; Liu, W. L.; Li, M. Z.; Zhang, L.; Kang, T. B.; Fu, L. W.; Huang, W. L.; Xia, Y. F.; Tsao, S. W.; Li, M.; Band, V.; Band, H.; Shi, Q. H.; Zeng, Y. X.; Zeng, M. S. The polycomb group protein Bmi-1 represses the tumor suppressor PTEN and induces epithelial-mesenchymal transition in human nasopharyngeal epithelial cells. J. Clin. Invest. 2009, 119(12), 3626-3636.
109. Huang, W.; Gonzalez, M. E.; Toy, K. A.; Banerjee, M.; Kleer, C. G. Blockade of CCN6 (WISP3) activates growth factorindependent survival and resistance to anoikis in human mammary epithelial cells. Cancer Res. 2010, 70(8), 3340-3350.
110. Lorenzatti, G.; Huang, W.; Pal, A.; Cabanillas, A. M.; Kleer, C. G. CCN6 (WISP3) decreases ZEB1-mediated EMT and invasion by attenuation of IGF-1 receptor signaling in breast cancer. J. Cell Sci. 2011, 124(Pt 10), 1752-1758.
111. Huang, W.; Pal, A.; Kleer, C. G. On how CCN6 suppresses breast cancer growth and invasion. J. Cell Commun. Signal. 2012, 6(1), 5-10.
112. Liu, M.; Casimiro, M. C.; Wang, C.; Shirley, L. A.; Jiao, X.; Katiyar, S.; Ju, X.; Li, Z.; Yu, Z.; Zhou, J. p21CIP1 attenuates Rasand c-Myc-dependent breast tumor epithelial mesenchymal transition and cancer stem cell-like gene expression in vivo. Proc. Natl. Acad. Sci. USA 2009, 106(45), 19035-19039.
113. Bullock, M. D.; Sayan, A. E.; Packham, G. K.; Mirnezami, A. H. MicroRNAs: critical regulators of epithelial to mesenchymal (EMT) and mesenchymal to epithelial transition (MET) in cancer progression. Biol. Cell. 2012, 104(1), 3-12.
114. Xia, H.; Ooi, L. L.; Hui, K. M. MiR-216a/217-induced epithelialmesenchymal transition targets PTEN and SMAD7 to promote drug resistance and recurrence of liver cancer. Hepatology 2013, 58(2), 629-641.
115. Han, M.; Liu, M.; Wang, Y.; Mo, Z.; Bi, X.; Liu, Z.; Fan, Y.; Chen, X.; Wu, C. Re-expression of miR-21 contributes to migration and invasion by inducing epithelial-mesenchymal transition consistent with cancer stem cell characteristics in MCF-7 cells. Mol. Cell. Biochem. 2012, 363(1-2), 427-436.
116. Coppola, V.; Musumeci, M.; Patrizii, M.; Cannistraci, A.; Addario, A.; Maugeri-Sacca, M.; Biffoni, M.; Francescangeli, F.; Cordenonsi, M.; Piccolo, S.; Memeo, L.; Pagliuca, A.; Muto, G.; Zeuner, A.; De Maria, R.; Bonci, D. BTG2 loss and miR-21 upregulation contribute to prostate cell transformation by inducing luminal markers expression and epithelial-mesenchymal transition. Oncogene 2013, 32(14), 1843-1853.
117. Zhang, Z.; Liu, S.; Shi, R.; Zhao, G. miR-27 promotes human gastric cancer cell metastasis by inducing epithelial-tomesenchymal transition. Cancer Genet. 2011, 204(9), 486-491.
118. Li, B. L.; Lu, C.; Lu, W.; Yang, T. T.; Qu, J.; Hong, X.; Wan, X. P. miR-130b is an EMT-related microRNA that targets DICER1 for aggression in endometrial cancer. Med. Oncol. 2013, 30(1), 484.
119. Dong, P.; Kaneuchi, M.; Watari, H.; Hamada, J.; Sudo, S.; Ju, J.; Sakuragi, N. MicroRNA-194 inhibits epithelial to mesenchymal transition of endometrial cancer cells by targeting oncogene BMI-1. Mol. Cancer 2011, 10, 99.
120. Hamada, S.; Satoh, K.; Miura, S.; Hirota, M.; Kanno, A.; Masamune, A.; Kikuta, K.; Kume, K.; Unno, J.; Egawa, S.; Motoi, F.; Unno, M.; Shimosegawa, T. miR-197 induces epithelialmesenchymal transition in pancreatic cancer cells by targeting p120 catenin. J. Cell. Physiol. 2013, 228(6), 1255-1263.
121. Stinson, S.; Lackner, M. R.; Adai, A. T.; Yu, N.; Kim, H. J.; O'Brien, C.; Spoerke, J.; Jhunjhunwala, S.; Boyd, Z.; Januario, T.; Newman, R. J.; Yue, P.; Bourgon, R.; Modrusan, Z.; Stern, H. M.; Warming, S.; de Sauvage, F. J.; Amler, L.; Yeh, R. F.; Dornan, D. TRPS1 targeting by miR-221/222 promotes the epithelial-tomesenchymal transition in breast cancer. Sci. Signal. 2011, 4(177), ra41.
122. Zhang, L. Y.; Liu, M.; Li, X.; Tang, H. miR-490-3p modulates cell growth and epithelial to mesenchymal transition of hepatocellular carcinoma cells by targeting endoplasmic reticulum-Golgi intermediate compartment protein 3 (ERGIC3). J. Biol. Chem. 2013, 288(6), 4035-4047.
123. Zhang, K.; Zhang, H.; Zhou, X.; Tang, W. B.; Xiao, L.; Liu, Y. H.; Liu, H.; Peng, Y. M.; Sun, L.; Liu, F. Y. miRNA589 regulates epithelial-mesenchymal transition in human peritoneal mesothelial cells. J. Biomed. Biotechnol. 2012, 2012, 673096.
124. Kumarswamy, R.; Mudduluru, G.; Ceppi, P.; Muppala, S.; Kozlowski, M.; Niklinski, J.; Papotti, M.; Allgayer, H. MicroRNA-30a inhibits epithelial-to-mesenchymal transition by targeting Snai1 and is downregulated in non-small cell lung cancer. Int. J. Cancer 2012, 130(9), 2044-2053.
125. Zhang, J.; Zhang, H.; Liu, J.; Tu, X.; Zang, Y.; Zhu, J.; Chen, J.; Dong, L.; Zhang, J. miR-30 inhibits TGF-beta1-induced epithelialto-mesenchymal transition in hepatocyte by targeting Snail1. Biochem. Bioph. Res. Co. 2012, 417(3), 1100-1105.
126. Siemens, H.; Jackstadt, R.; Hunten, S.; Kaller, M.; Menssen, A.; Gotz, U.; Hermeking, H. miR-34 and SNAIL form a doublenegative feedback loop to regulate epithelial-mesenchymal transitions. Cell Cycle 2011, 10(24), 4256-4271.
127. Li, J.; Wang, Y.; Luo, J.; Fu, Z.; Ying, J.; Yu, Y.; Yu, W. miR-134 inhibits epithelial to mesenchymal transition by targeting FOXM1 in non-small cell lung cancer cells. FEBS Lett. 2012, 586(20), 3761-3765.
128. Ke, Y.; Zhao, W.; Xiong, J.; Cao, R. miR-149 Inhibits non-smallcell lung cancer cells EMT by targeting FOXM1. Biochem. Res. Int. 2013, 2013, 506731.
129. Liu, X.; Wang, C.; Chen, Z.; Jin, Y.; Wang, Y.; Kolokythas, A.; Dai, Y.; Zhou, X. MicroRNA-138 suppresses epithelial-mesenchymal transition in squamous cell carcinoma cell lines. Biochem. J. 2011, 440(1), 23-31.
130. Yokobori, T.; Suzuki, S.; Tanaka, N.; Inose, T.; Sohda, M.; Sano, A.; Sakai, M.; Nakajima, M.; Miyazaki, T.; Kato, H.; Kuwano, H. MiR-150 is associated with poor prognosis in esophageal squamous cell carcinoma via targeting the EMT inducer ZEB1. Cancer Sci. 2013, 104(1), 48-54.
131. Xu, Q.; Sun, Q.; Zhang, J.; Yu, J.; Chen, W.; Zhang, Z. Downregulation of miR-153 contributes to epithelial-mesenchymal transition and tumor metastasis in human epithelial cancer. Carcinogenesis 2013, 34(3), 539-549.
132. Feng, B.; Wang, R.; Chen, L. B. Review of miR-200b and cancer chemosensitivity. Biomed. Pharmacother. 2012, 66(6), 397-402.
133. Cong, N.; Du, P.; Zhang, A.; Shen, F.; Su, J.; Pu, P.; Wang, T.; Zjang, J.; Kang, C.; Zhang, Q. Downregulated microRNA-200a promotes EMT and tumor growth through the wnt/beta-catenin pathway by targeting the E-cadherin repressors ZEB1/ZEB2 in gastric adenocarcinoma. Oncol. Rep. 2013, 29(4), 1579-1587.
134. Cai, Z. G.; Zhang, S. M.; Zhang, H.; Zhou, Y. Y.; Wu, H. B.; Xu, X. P. Aberrant expression of microRNAs involved in epithelialmesenchymal transition of HT-29 cell line. Cell Biol. Int. 2013, 37(7), 669-674.
135. Gregory, P. A.; Bert, A. G.; Paterson, E. L.; Barry, S. C.; Tsykin, A.; Farshid, G.; Vadas, M. A.; Khew-Goodall, Y.; Goodall, G. J. The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1. Nat. Cell Biol. 2008, 10(5), 593-601.
136. Chen, Y.; Xiao, Y.; Ge, W.; Zhou, K.; Wen, J.; Yan, W.; Wang, Y.; Wang, B.; Qu, C.; Wu, J.; Xu, L.; Cai, W. miR-200b inhibits TGFbeta1-induced epithelial-mesenchymal transition and promotes growth of intestinal epithelial cells. Cell Death Dis. 2013, 4, e541.
137. Tang, O.; Chen, X. M.; Shen, S.; Hahn, M.; Pollock, C. A. MiRNA-200b represses transforming growth factor-beta1-induced EMT and fibronectin expression in kidney proximal tubular cells. Am. J. Physiol. Renal Physiol. 2013, 304(10), F1266-1273.
138. Oishi, N.; Kumar, M. R.; Roessler, S.; Ji, J.; Forgues, M.; Budhu, A.; Zhao, X.; Andersen, J. B.; Ye, Q. H.; Jia, H. L.; Qin, L. X.; Yamashita, T.; Woo, H. G.; Kim, Y. J.; Kaneko, S.; Tang, Z. Y.; Thorgeirsson, S. S.; Wang, X. W. Transcriptomic profiling reveals hepatic stem-like gene signatures and interplay of miR-200c and epithelial-mesenchymal transition in intrahepatic cholangiocarcinoma. Hepatology 2012, 56(5), 1792-1803.
139. Liu, Y. N.; Yin, J. J.; Abou-Kheir, W.; Hynes, P. G.; Casey, O. M.; Fang, L.; Yi, M.; Stephens, R. M.; Seng, V.; Sheppard-Tillman, H.; Martin, P.; Kelly, K. MiR-1 and miR-200 inhibit EMT via Slugdependent and tumorigenesis via Slug-independent mechanisms. Oncogene 2013, 32(3), 296-306.
140. Ding, X.; Park, S. I.; McCauley, L. K.; Wang, C. Y. Signaling between transforming growth factor beta (TGF-beta) and transcription factor SNAI2 represses expression of microRNA miR-203 to promote epithelial-mesenchymal transition and tumor metastasis. J. Biol. Chem. 2013, 288(15), 10241-10253.
141. Zhou, Y.; Li, Y.; Ye, J.; Jiang, R.; Yan, H.; Yang, X.; Liu, Q.; Zhang, J. MicroRNA-491 is involved in metastasis of hepatocellular carcinoma by inhibitions of matrix metalloproteinase and epithelial to mesenchymal transition. Liver Int. 2013, 33(8), 1271-1280
142. Arora, H.; Qureshi, R.; Park, W. Y. miR-506 regulates epithelial mesenchymal transition in breast cancer cell lines. PLoS One 2013, 8(5), e64273.
143. Harazono, Y.; Muramatsu, T.; Endo, H.; Uzawa, N.; Kawano, T.; Harada, K.; Inazawa, J.; Kozaki, K. miR-655 Is an EMTSuppressive MicroRNA Targeting ZEB1 and TGFBR2. PLoS One 2013, 8(5), e62757.
144. Body, J. J. Bisphosphonates in the treatment of metastatic breast cancer. J. Mammary Gland Biol. Neoplasia 2001, 6(4), 477-485.
145. Connolly, E. C.; Freimuth, J.; Akhurst, R. J. Complexities of TGFbeta targeted cancer therapy. Int. J. Biol. Sci. 2012, 8(7), 964-978.
146. Fang, R.; Zhang, G.; Guo, Q.; Ning, F.; Wang, H.; Cai, S.; Du, J. Nodal promotes aggressive phenotype via Snail-mediated epithelial-mesenchymal transition in murine melanoma. Cancer Lett. 2013, 333(1), 66-75.
147. Goustin, A. S.; Leof, E. B.; Shipley, G. D.; Moses, H. L. Growth factors and cancer. Cancer Res. 1986, 46(3), 1015-1029.
148. Lei, J.; Ma, J.; Ma, Q.; Li, X.; Liu, H.; Xu, Q.; Duan, W.; Sun, Q.; Xu, J.; Wu, Z.; Wu, E. Hedgehog signaling regulates hypoxia induced epithelial to mesenchymal transition and invasion in pancreatic cancer cells via a ligand-independent manner. Mol. Cancer 2013, 12(1), 66.
149. Li, M.; Hering-Smith, K. S.; Simon, E. E.; Batuman, V. Myeloma light chains induce epithelial-mesenchymal transition in human renal proximal tubule epithelial cells. Nephrol. Dial. Transpl. 2008, 23(3), 860-870.
150. Lippman, M. E.; Dickson, R. B.; Gelmann, E. P.; Rosen, N.; Knabbe, C.; Bates, S.; Bronzert, D.; Huff, K.; Kasid, A. Growth regulation of human breast carcinoma occurs through regulated growth factor secretion. J. Cell. Biochem. 1987, 35(1), 1-16.
151. Matsumoto, K. [Molecular mechanisms of sex steroid-induced growth of cancer cells] Hum. Cell 1993, 6(3), 153-160.
152. Quail, D. F.; Zhang, G.; Findlay, S. D.; Hess, D. A.; Postovit, L. M. Nodal promotes invasive phenotypes via a mitogen-activated protein kinase-dependent pathway. Oncogene 2013, doi: 10.1038/onc.2012.608. [Epub ahead of print]
153. Shah, A. H.; Lee, C. TGF-beta-based immunotherapy for cancer: breaching the tumor firewall. Prostate 2000, 45(2), 167-172.
154. Park, J. K.; Jang, S. J.; Kang, S. W.; Park, S.; Hwang, S.-G.; Kim, W.-J.; Kang, J. H.; Um, H.-D. Establishment of animal model for the analysis of cancer cell metastasis during radiotherapy. Radiat. Oncol. 2012, 7(1), 1-11.
155. Akkari, L.; Gregoire, D.; Floc'h, N.; Moreau, M.; Hernandez, C.; Simonin, Y.; Rosenberg, A. R.; Lassus, P.; Hibner, U. Hepatitis C viral protein NS5A induces EMT and participates in oncogenic transformation of primary hepatocyte precursors. J. Hepatol. 2012, 57(5), 1021-1028.
156. Bose, S. K.; Meyer, K.; Di Bisceglie, A. M.; Ray, R. B.; Ray, R. Hepatitis C virus induces epithelial-mesenchymal transition in primary human hepatocytes. J. Virol. 2012, 86(24), 13621-13628.
157. Shimamura, M.; Murphy-Ullrich, J. E.; Britt, W. J. Human cytomegalovirus induces TGF-beta1 activation in renal tubular epithelial cells after epithelial-to-mesenchymal transition. PLoS Pathog. 2010, 6(11), e1001170.
158. Chamulitrat, W.; Sattayakhom, A.; Herold-Mende, C.; Stremmel, W. Human papillomavirus 16 E6/E7-immortalized human gingival keratinocytes with epithelial mesenchymal transition acquire increased expression of cIAP-1, Bclx and p27(Kip1). Exp. Dermatol. 2009, 18(12), 1067-1069.
159. Jung, J.-W.; Hwang, S.-Y.; Hwang, J.-S.; Oh, E.-S.; Park, S.; Han, I.-O. Ionising radiation induces changes associated with epithelialmesenchymal transdifferentiation and increased cell motility of A549 lung epithelial cells. Eur. J. Cancer 2007, 43(7), 1214-1224.
160. Andarawewa, K. L.; Erickson, A. C.; Chou, W. S.; Costes, S. V.; Gascard, P.; Mott, J. D.; Bissell, M. J.; Barcellos-Hoff, M. H. Ionizing radiation predisposes nonmalignant human mammary epithelial cells to undergo transforming growth factor beta induced epithelial to mesenchymal transition. Cancer Res. 2007, 67(18), 8662-8670.
161. Battaglia, S.; Benzoubir, N.; Nobilet, S.; Charneau, P.; Samuel, D.; Zignego, A. L.; Atfi, A.; Brechot, C.; Bourgeade, M. F. Liver cancer-derived hepatitis C virus core proteins shift TGF-beta responses from tumor suppression to epithelial-mesenchymal transition. PLoS One 2009, 4(2), e4355.
162. Davis, R.; Rizwani, W.; Banerjee, S.; Kovacs, M.; Haura, E.; Coppola, D.; Chellappan, S. Nicotine promotes tumor growth and metastasis in mouse models of lung cancer. PLoS One 2009, 4(10), e7524.
163. Gagliano, N.; Torri, C.; Donetti, E.; Grizzi, F.; Costa, F.; Bertelli, A. A.; Migliori, M.; Filippi, C.; Bedoni, M.; Panichi, V. Ochratoxin a induced renal cortex fibrosis and epithelial-to-mesenchymal transition: Molecular mechanisms of ochratoxin A-injury and potential effects of red wine. Mol. Med. 2005, 11(1-12), 30.
164. Li, T.; Zeng, Z. C.; Wang, L.; Qiu, S. J.; Zhou, J. W.; Zhi, X. T.; Yu, H. H.; Tang, Z. Y. Radiation enhances long-term metastasis potential of residual hepatocellular carcinoma in nude mice through TMPRSS4-induced epithelial-mesenchymal transition. Cancer Gene Ther. 2011, 18(9), 617-626.
165. Kawamoto, A.; Yokoe, T.; Tanaka, K.; Saigusa, S.; Toiyama, Y.; Yasuda, H.; Inoue, Y.; Miki, C.; Kusunoki, M. Radiation induces epithelial-mesenchymal transition in colorectal cancer cells. Oncol. Rep. 2012, 27(1), 51-57.
166. Newkirk, K. M.; Parent, A. E.; Fossey, S. L.; Choi, C.; Chandler, H. L.; Rajala-Schultz, P. J.; Kusewitt, D. F. Snai2 expression enhances ultraviolet radiation-induced skin carcinogenesis. Am. J. Pathol. 2007, 171(5), 1629-1639.
167. Severi, T.; van Malenstein, H.; Verslype, C.; van Pelt, J. F. Tumor initiation and progression in hepatocellular carcinoma: risk factors, classification, and therapeutic targets. Acta Pharmacol. Sin. 2010, 31(11), 1409-1420.
168. Horikawa, T.; Yang, J.; Kondo, S.; Yoshizaki, T.; Joab, I.; Furukawa, M.; Pagano, J. S. Twist and epithelial-mesenchymal transition are induced by the EBV oncoprotein latent membrane protein 1 and are associated with metastatic nasopharyngeal carcinoma. Cancer Res. 2007, 67(5), 1970-1978.
169. Hudson, L. G.; Choi, C.; Newkirk, K. M.; Parkhani, J.; Cooper, K. L.; Lu, P.; Kusewitt, D. F. Ultraviolet radiation stimulates expression of Snail family transcription factors in keratinocytes. Mol. Carcinog. 2007, 46(4), 257-268.
170. Du, R.; Huang, C.; Bi, Q.; Zhai, Y.; Xia, L.; Liu, J.; Sun, S.; Fan, D. URG11 mediates hypoxia-induced epithelial-to-mesenchymal transition by modulation of E-cadherin and beta-catenin. Biochem. Bioph. Res. Co. 2010, 391(1), 135-141.
171. Zucchini-Pascal, N.; Peyre, L.; de Sousa, G.; Rahmani, R. Organochlorine pesticides induce epithelial to mesenchymal transition of human primary cultured hepatocytes. Food Chem. Toxicol. 2012, 50(11), 3963-3970.
172. Peyre, L.; Zucchini-Pascal, N.; de Sousa, G.; Rahmani, R. Effects of endosulfan on hepatoma cell adhesion: Epithelial-mesenchymal transition and anoikis resistance. Toxicology 2012, 300(1-2), 19-30.
173. Tellez, C. S.; Juri, D. E.; Do, K.; Bernauer, A. M.; Thomas, C. L.; Damiani, L. A.; Tessema, M.; Leng, S.; Belinsky, S. A. EMT and stem cell-like properties associated with miR-205 and miR-200 epigenetic silencing are early manifestations during carcinogeninduced transformation of human lung epithelial cells. Cancer Res. 2011, 71(8), 3087-3097.
174. Tamminen, J. A.; Myllärniemi, M.; Hyytiäinen, M.; Keski-Oja, J.; Koli, K. Asbestos exposure induces alveolar epithelial cell plasticity through MAPK/Erk signaling. J. Cell. Biochem. 2012, 113(7), 2234-2247.
175. Yang, S. Z.; Zhang, L. D.; Zhang, Y.; Xiong, Y.; Zhang, Y. J.; Li, H. L.; Li, X. W.; Dong, J. H. HBx protein induces EMT through c-Src activation in SMMC-7721 hepatoma cell line. Biochem. Bioph. Res. Co. 2009, 382(3), 555-560.
176. Teng, J.; Wang, X.; Xu, Z.; Tang, N. HBx-dependent activation of twist mediates STAT3 control of epithelium-mesenchymal transition of liver cells. J. Cell. Biochem. 2013, 114(5), 1097-1104.
177. Li, T.; Li, D.; Cheng, L.; Wu, H.; Gao, Z.; Liu, Z.; Jiang, W.; Gao, Y. H.; Tian, F.; Zhao, L.; Wang, S. Epithelial-mesenchymal transition induced by hepatitis C virus core protein in cholangiocarcinoma. Ann. Surg. Oncol. 2010, 17(7), 1937-1944.
178. Kondo, S.; Wakisaka, N.; Muramatsu, M.; Zen, Y.; Endo, K.; Murono, S.; Sugimoto, H.; Yamaoka, S.; Pagano, J. S.; Yoshizaki, T. Epstein-Barr virus latent membrane protein 1 induces cancer stem/progenitor-like cells in nasopharyngeal epithelial cell lines. J. Virol. 2011, 85(21), 11255-11264.
179. Sides, M. D.; Klingsberg, R. C.; Shan, B.; Gordon, K. A.; Nguyen, H. T.; Lin, Z.; Takahashi, T.; Flemington, E. K.; Lasky, J. A. The Epstein-Barr virus latent membrane protein 1 and transforming growth factor-beta1 synergistically induce epithelial-mesenchymal transition in lung epithelial cells. Am. J. Respir. Cell Mol. Biol. 2011, 44(6), 852.
180. Kong, Q. L.; Hu, L. J.; Cao, J. Y.; Huang, Y. J.; Xu, L. H.; Liang, Y.; Xiong, D.; Guan, S.; Guo, B. H.; Mai, H. Q.; Chen, Q. Y.; Zhang, X.; Li, M. Z.; Shao, J. Y.; Qian, C. N.; Xia, Y. F.; Song, L. B.; Zeng, Y. X.; Zeng, M. S. Epstein-Barr virus-encoded LMP2A induces an epithelial-mesenchymal transition and increases the number of side population stem-like cancer cells in nasopharyngeal carcinoma. PLoS Pathog. 2010, 6(6), e1000940.
181. Strauss, R.; Sova, P.; Liu, Y.; Li, Z. Y.; Tuve, S.; Pritchard, D.; Brinkkoetter, P.; Moller, T.; Wildner, O.; Pesonen, S.; Hemminki, A.; Urban, N.; Drescher, C.; Lieber, A. Epithelial phenotype confers resistance of ovarian cancer cells to oncolytic adenoviruses. Cancer Res. 2009, 69(12), 5115-5125.
182. Yan, S.; Wang, Y.; Yang, Q.; Li, X.; Kong, X.; Zhang, N.; Yuan, C.; Yang, N.; Kong, B. Low-dose radiation-induced epithelialmesenchymal transition through NF-kappaB in cervical cancer cells. Int. J. Oncol. 2013, 42(5), 1801-1806.
183. Zhang, X.; Li, X.; Zhang, N.; Yang, Q.; Moran, M. S. Low doses ionizing radiation enhances the invasiveness of breast cancer cells by inducing epithelial-mesenchymal transition. Biochem. Bioph. Res. Co. 2011, 412(1), 188-192.
184. Jiang, J.; Tang, Y. L.; Liang, X. H. EMT: a new vision of hypoxia promoting cancer progression. Cancer Biol. Ther. 2011, 11(8), 714-723.
185. Zhou, J.; Li, K.; Gu, Y.; Feng, B.; Ren, G.; Zhang, L.; Wang, Y.; Nie, Y.; Fan, D. Transcriptional up-regulation of RhoE by hypoxiainducible factor (HIF)-1 promotes epithelial to mesenchymal transition of gastric cancer cells during hypoxia. Biochem. Bioph. Res. Co. 2011, 415(2), 348-354.
186. Okajima, M.; Kokura, S.; Ishikawa, T.; Mizushima, K.; Tsuchiya, R.; Matsuyama, T.; Adachi, S.; Okayama, T.; Sakamoto, N.; Kamada, K.; Katada, K.; Uchiyama, K.; Handa, O.; Takagi, T.; Yagi, N.; Naito, Y.; Yoshikawa, T. Anoxia/reoxygenation induces epithelial-mesenchymal transition in human colon cancer cell lines. Oncol. Rep. 2013, 29(6), 2311-2317.
187. Copple, B. L. Hypoxia stimulates hepatocyte epithelial to mesenchymal transition by hypoxia-inducible factor and transforming growth factor-beta-dependent mechanisms. Liver Int. 2010, 30(5), 669-682.
188. Zhang, L.; Huang, G.; Li, X.; Zhang, Y.; Jiang, Y.; Shen, J.; Liu, J.; Wang, Q.; Zhu, J.; Feng, X.; Dong, J.; Qian, C. Hypoxia induces epithelial-mesenchymal transition via activation of SNAI1 by hypoxia-inducible factor-1alpha in hepatocellular carcinoma. BMC Cancer 2013, 13, 108.
189. Salnikov, A. V.; Liu, L.; Platen, M.; Gladkich, J.; Salnikova, O.; Ryschich, E.; Mattern, J.; Moldenhauer, G.; Werner, J.; Schemmer, P.; Buchler, M. W.; Herr, I. Hypoxia induces EMT in low and highly aggressive pancreatic tumor cells but only cells with cancer stem cell characteristics acquire pronounced migratory potential. PLoS One 2012, 7(9), e46391.
190. Azab, A. K.; Hu, J.; Quang, P.; Azab, F.; Pitsillides, C.; Awwad, R.; Thompson, B.; Maiso, P.; Sun, J. D.; Hart, C. P.; Roccaro, A. M.; Sacco, A.; Ngo, H. T.; Lin, C. P.; Kung, A. L.; Carrasco, R. D.; Vanderkerken, K.; Ghobrial, I. M. Hypoxia promotes dissemination of multiple myeloma through acquisition of epithelial to mesenchymal transition-like features. Blood 2012, 119(24), 5782-5794.
191. Oh, E. J.; Ryu, H. M.; Choi, S. Y.; Yook, J. M.; Kim, C. D.; Park, S. H.; Chung, H. Y.; Kim, I. S.; Yu, M. A.; Kang, D. H.; Kim, Y. L. Impact of low glucose degradation product bicarbonate/lactatebuffered dialysis solution on the epithelial-mesenchymal transition of peritoneum. Am. J. Nephrol. 2010, 31(1), 58-67.
192. Pani, G.; Galeotti, T.; Chiarugi, P. Metastasis: cancer cell's escape from oxidative stress. Cancer Metast. Rev. 2010, 29(2), 351-378.
193. Zhou, F.; Shen, Q.; Claret, F. X. Novel roles of reactive oxygen species in the pathogenesis of acute myeloid leukemia. J. Leukoc. Biol. 2013, 94(3), 423-429.
194. Fiaschi, T.; Marini, A.; Giannoni, E.; Taddei, M. L.; Gandellini, P.; De Donatis, A.; Lanciotti, M.; Serni, S.; Cirri, P.; Chiarugi, P. Reciprocal metabolic reprogramming through lactate shuttle coordinately influences tumor-stroma interplay. Cancer Res. 2012, 72(19), 5130-5140.
195. Dong, R.; Wang, Q.; He, X. L.; Chu, Y. K.; Lu, J. G.; Ma, Q. J. Role of nuclear factor kappa B and reactive oxygen species in the tumor necrosis factor-alpha-induced epithelial-mesenchymal transition of MCF-7 cells. Braz. J. Med. Biol. Res. 2007, 40(8), 1071-1078.
196. Rhyu, D. Y.; Park, J.; Sharma, B. R.; Ha, H. Role of reactive oxygen species in transforming growth factor-beta1-induced extracellular matrix accumulation in renal tubular epithelial cells. Transplant. Proc. 2012, 44(3), 625-628.
197. Foroni, L.; Vasuri, F.; Valente, S.; Gualandi, C.; Focarete, M. L.; Caprara, G.; Scandola, M.; D'Errico-Grigioni, A.; Pasquinelli, G. The role of 3D microenvironmental organization in MCF-7 epithelial-mesenchymal transition after 7 culture days. Exp. Cell Res. 2013, 319(10), 1515-1522.
198. Martinez-Outschoorn, U. E.; Prisco, M.; Ertel, A.; Tsirigos, A.; Lin, Z.; Pavlides, S.; Wang, C.; Flomenberg, N.; Knudsen, E. S.; Howell, A.; Pestell, R. G.; Sotgia, F.; Lisanti, M. P. Ketones and lactate increase cancer cell "stemness, " driving recurrence, metastasis and poor clinical outcome in breast cancer: achieving personalized medicine via Metabolo-Genomics. Cell Cycle 2011, 10(8), 1271-1286.
199. Bonuccelli, G.; Tsirigos, A.; Whitaker-Menezes, D.; Pavlides, S.; Pestell, R. G.; Chiavarina, B.; Frank, P. G.; Flomenberg, N.; Howell, A.; Martinez-Outschoorn, U. E.; Sotgia, F.; Lisanti, M. P. Ketones and lactate "fuel" tumor growth and metastasis: Evidence that epithelial cancer cells use oxidative mitochondrial metabolism. Cell Cycle 2010, 9(17), 3506-3514.
200. Giannoni, E.; Parri, M.; Chiarugi, P. EMT and oxidative stress: a bidirectional interplay affecting tumor malignancy. Antioxid. Redox Sign. 2012, 16(11), 1248-1263.
201. Cannito, S.; Novo, E.; di Bonzo, L. V.; Busletta, C.; Colombatto, S.; Parola, M. Epithelial-mesenchymal transition: from molecular mechanisms, redox regulation to implications in human health and disease. Antioxid. Redox Sign. 2010, 12(12), 1383-1430.
202. Zhou, F.; Shen, Q.; Claret, F. X. Novel roles of reactive oxygen species in the pathogenesis of acute myeloid leukemia. J. Leukoc. Biol. 2013, 94(3), 423-429.
203. Cheng, C. W.; Kuo, C. Y.; Fan, C. C.; Fang, W. C.; Jiang, S. S.; Lo, Y. K.; Wang, T. Y.; Kao, M. C.; Lee, A. Y. Overexpression of Lon contributes to survival and aggressive phenotype of cancer cells through mitochondrial complex I-mediated generation of reactive oxygen species. Cell Death Dis. 2013, 4, e681.
204. Giannoni, E.; Parri, M.; Chiarugi, P. EMT and oxidative stress: a bidirectional interplay affecting tumor malignancy. Antioxid. Redox Sign. 2012, 16(11), 1248-1263.
205. Nogueira, V.; Hay, N. Molecular Pathways: Reactive Oxygen Species Homeostasis in Cancer Cells and Implications for Cancer Therapy. Clin. Cancer Res. 2013, 19(16), 4309-4314.
206. Khan, H. Y.; Zubair, H.; Ullah, M. F.; Ahmad, A.; Hadi, S. M. A prooxidant mechanism for the anticancer and chemopreventive properties of plant polyphenols. Curr. Drug Targets 2012, 13(14), 1738-1749.
207. Das, T. P.; Suman, S.; Damodaran, C. Reactive oxygen species generation inhibits epithelial-mesenchymal transition and promotes growth arrest in prostate cancer cells. Mol. Carcinog. 2013. doi: 10.1002/mc.22014. [Epub ahead of print]
208. Jing, Y.; Han, Z.; Zhang, S.; Liu, Y.; Wei, L. Epithelial-Mesenchymal Transition in tumor microenvironment. Cell Biosci. 2011, 1, 29.
209. Zhang, G.; Yang, P.; Guo, P.; Miele, L.; Sarkar, F. H.; Wang, Z.; Zhou, Q. Unraveling the mystery of cancer metabolism in the genesis of tumor-initiating cells and development of cancer. Biochim. Biophys. Acta 2013, 1836(1), 49-59.
210. Moustakas, A.; Pardali, K.; Gaal, A.; Heldin, C. H. Mechanisms of TGF-beta signaling in regulation of cell growth and differentiation. Immunol. Lett. 2002, 82(1-2), 85-91.
211. Reiman, J. M.; Knutson, K. L.; Radisky, D. C. Immune promotion of epithelial-mesenchymal transition and generation of breast cancer stem cells. Cancer Res. 2010, 70(8), 3005-3008.
212. Sullivan, N. J.; Sasser, A. K.; Axel, A. E.; Vesuna, F.; Raman, V.; Ramirez, N.; Oberyszyn, T. M.; Hall, B. M. Interleukin-6 induces an epithelial-mesenchymal transition phenotype in human breast cancer cells. Oncogene 2009, 28(33), 2940-2947.
213. Xie, G.; Yao, Q.; Liu, Y.; Du, S.; Liu, A.; Guo, Z.; Sun, A.; Ruan, J.; Chen, L.; Ye, C.; Yuan, Y. IL-6-induced epithelialmesenchymal transition promotes the generation of breast cancer stem-like cells analogous to mammosphere cultures. Int. J. Oncol. 2012, 40(4), 1171-1179.